THAR – tharimmune, inc. (US:NASDAQ)
Stock Stats
News
Tharimmune (NASDAQ:THAR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network
Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy
Tharimmune (NASDAQ:THAR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Tharimmune (NASDAQ:THAR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 424B3 Tharimmune, Inc.
Form EFFECT Tharimmune, Inc.
Form PRE 14A Tharimmune, Inc. For: Dec 16
Form 8-K Tharimmune, Inc. For: Dec 10
Form S-3 Tharimmune, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.